Routine Antibiotics Unneeded for CKD Cat UTI

Subclinical Urinary Infections in CKD Cats: No Need for Routine Antibiotics

Two hundred eighty-seven cats with chronic kidney disease (CKD) from four French veterinary hospitals formed the basis of a new study. Published in the Journal of Veterinary Internal Medicine, researchers led by Elodie Le Corre of Oniris VetAgroBio set out to clarify a common clinical dilemma: how to manage subclinical bacteriuria (SBU). This condition, where bacteria are present in urine without causing visible symptoms like straining or discomfort, is frequent in CKD cats. The research questioned whether this hidden infection worsened kidney disease or shortened life, and whether antibiotics were a beneficial intervention.

Hidden Bacteria in CKD Cats: No Link to Survival or Progression

The multicenter retrospective study analyzed cats diagnosed with CKD according to International Renal Interest Society (IRIS) guidelines. All cats had a urine culture obtained by sterile cystocentesis and showed no signs of lower urinary tract disease. The cohort was split into an SBU group (108 cats) and a control group without bacteriuria (179 cats). The primary aim was to determine if SBU influenced survival time or the frequency of CKD progression.

Using multivariate Cox regression analysis, the team found no significant association. The hazard ratio for survival in SBU cats was 0.68, with a confidence interval crossing 1, and a P-value of .16. This means the presence of SBU did not predict earlier death. Similarly, the frequency of CKD progression—measured by increases in IRIS stage or plasma creatinine—was not different between groups (P = .84). Instead, the analysis confirmed known risk factors: each unit increase in plasma creatinine was linked to a 2% increase in hazard, and a better body condition score significantly improved survival odds.

The study design has limitations common to retrospective analyses, such as potential variability in record-keeping across hospitals. However, its large sample size and stringent inclusion criteria provide robust evidence against SBU as a primary driver of CKD decline.

Antimicrobial Treatment Often Failed and Was Not Protective

A striking secondary finding involved treatment outcomes. Despite having no clinical signs, 85 of the 108 SBU cats (78%) received antimicrobial therapy. This treatment did not reliably eradicate the bacteria; persistence or recolonization was common. More importantly, progression to an active, symptomatic infection—either bacterial cystitis or the more serious pyelonephritis, a kidney infection—occurred in some cats regardless of whether they received antibiotics.

This suggests that the relationship between SBU and active urinary tract disease is complex. SBU may represent a state of bacterial colonization that the immune system manages, rather than an inevitable precursor to symptomatic infection. The authors explicitly state that these findings “do not support routine antimicrobial treatment of SBU in cats with CKD.” This challenges a common clinical reflex to prescribe antibiotics for a positive culture, emphasizing instead the importance of treating only when clear symptoms emerge.

From Urinary Tract to Heart: A Rare But Severe Pathway

While SBU may often be benign, another recent case report underscores that urinary bacteria can sometimes cause catastrophic illness. In a study published in Veterinary Research Communications, researchers from Bursa Uludag University in Turkey documented a cat diagnosed with Enterococcus faecalis-associated infective endocarditis.

Infective endocarditis is an infection of the heart valves. Bacteria, often originating from another site like the urinary tract, adhere to the valve surface, forming a biofilm and damaging tissue. This can lead to the formation of clots on the valve. In the reported case, a clot dislodged and traveled through the arterial system, causing a fatal arterial thromboembolism—a sudden blockage of blood flow, often to the hind limbs. While Enterococcus faecalis is not a common feline pathogen, this case illustrates a potential, albeit rare, severe consequence of bacterial dissemination from a source like the urinary tract.

Practical Guidance for Cat Owners and Veterinarians

For owners of cats with chronic kidney disease, these studies offer clarity and caution. Monitoring a cat’s weight and body condition remains a critical, actionable focus, as a good body condition score strongly correlates with better survival. Regular veterinary check-ups to monitor creatinine levels are essential. If a urine test reveals bacteria but the cat is acting normally—eating, drinking, urinating without strain—the new evidence suggests that immediate antibiotic treatment may not be necessary or beneficial. This approach also aligns with global efforts to reduce unnecessary antibiotic use.

Veterinarians are encouraged to adopt a symptom-driven treatment strategy. For asymptomatic CKD cats with bacteriuria, careful observation may be the best course. Treatment should be reserved for cats developing signs like frequent urination, crying in the litter box, or passing bloody urine. Managing the underlying CKD through diet, hydration, and other supportive care, as outlined in resources like our Feline CKD Diet Guide, is likely more impactful for long-term health than treating incidental SBU.

The rare possibility of severe systemic infection means that any cat showing sudden, severe signs like limb paralysis, extreme pain, or profound lethargy requires immediate emergency care, as these could indicate complications like thromboembolism.

Together, these studies refine our understanding of urinary infections in cats, particularly those with pre-existing kidney disease. They shift the focus from aggressively treating laboratory findings to thoughtfully managing the patient’s overall condition and clinical symptoms, an approach that benefits both feline health and antibiotic stewardship.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42012812/
https://pubmed.ncbi.nlm.nih.gov/41973353/